Summary
A case of posttraumatic stress disorder (PTSD) in the last days of life is presented. It shows insufficient pharmacological therapy and PTSD that was not recognized early enough. We discuss the dilemma caused by the necessity of a long-term psychotherapy and the challenge of little time being left at the end of life. Additionally, a language barrier can be a main reason for misinterpreting symptoms of PTSD.
Similar content being viewed by others
References
Glick DM, Cook JM, Moye J, Kaiser AP. Assessment and treatment considerations for post traumatic stress disorder at end of life. Am J Hosp Palliat Care. 2018;35(8):1133–9. https://doi.org/10.1177/1049909118756656.
Abdallah CG, Averill LA, Akiki TJ, Raza M, Averill CL, Gomaa H, et al. The neurobiology and pharmacotherapy of posttraumatic stress disorder. Annu Rev Pharmacol Toxicol. 2019;59:171–89. https://doi.org/10.1146/annurev-pharmtox-010818-021701.
Koenen KC, Ratanatharathorn A, Ng L, McLaughlin KA, Bromet EJ, Stein DJ, et al. Posttraumatic stress disorder in the world mental health surveys. Psychol Med. 2017;47(13):2260–74. https://doi.org/10.1017/S0033291717000708.
Fulton JJ, Calhoun PS, Wagner HR, Schry AR, Hair LP, Feeling N, et al. The prevalence of posttraumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans: a meta-analysis. J Anxiety Disord. 2015;31:98–107. https://doi.org/10.1016/j.janxdis.2015.02.003.
Abdallah CG, Averill LA, Krystal JH. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015a;1344(1):66–77. https://doi.org/10.1111/nyas.12718.
Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015b;66:509–23. https://doi.org/10.1146/annurev-med-053013-062946.
Averill LA, Purohit P, Averill CL, Boesl MA, Krystal JH, Abdallah CG. Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies. Neurosci Lett. 2017;649:147–55. https://doi.org/10.1016/j.neulet.2016.11.064.
Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, et al. Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep. 2017;19(10):74. https://doi.org/10.1007/s11920-017-0829-z.PMID:.
Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull. 2003;129(1):52–73. https://doi.org/10.1037/0033-2909.129.1.52.PMID:.
Zoladz PR, Diamond DM. Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature. Neurosci Biobehav Rev. 2013;37(5):860–95. https://doi.org/10.1016/j.neubiorev.2013.03.024.
Forbes D, Creamer M, Bisson JI, Cohen JA, Crow BE, Foa EB, et al. A guide to guidelines for the treatment of PTSD and related conditions. J Trauma Stress. 2010;23(5):537–52. https://doi.org/10.1002/jts.20565.
Friedman MJ, Bernardy NC. Considering future pharmacotherapy for PTSD. Neurosci Lett. 2017;649:181–5. https://doi.org/10.1016/j.neulet.2016.11.048.
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351–4. https://doi.org/10.1016/s0006-3223(99)00230-9.
McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. 2015;45(4):693–704. https://doi.org/10.1017/S0033291714001603.
Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(6):681–8. https://doi.org/10.1001/jamapsychiatry.2014.62.PMID:.
Krystal JH, Rosenheck RA, Cramer JA, Vessicchio JC, Jones KM, Vertrees JE, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493–502. https://doi.org/10.1001/jama.2011.1080.PMID:.
Guina J, Rossetter SR, DeRhodes BJ, Nahhas RW, Welton RS. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281–303. https://doi.org/10.1097/PRA.0000000000000091.
Kelmendi B, Adams TG, Yarnell S, Southwick S, Abdallah CG, Krystal JH. PTSD: from neurobiology to pharmacological treatments. Eur J Psychotraumatol. 2016;7:31858. https://doi.org/10.3402/ejpt.v7.31858.
Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020;177(5):391–410. https://doi.org/10.1176/appi.ajp.2019.19010035.
Ganzel BL. Trauma-informed hospice and palliative care. Gerontologist. 2018;58(3):409–19. https://doi.org/10.1093/geront/gnw146.
Hosie A, Davidson PM, Agar M, Sanderson CR, Phillips J. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med. 2013;27(6):486–98. https://doi.org/10.1177/0269216312457214.
Moye J, Rouse SJ. Posttraumatic stress in older adults: when medical diagnoses or treatments cause traumatic stress. Psychiatr Clin North Am. 2015;38(1):45–57. https://doi.org/10.1016/j.psc.2014.11.003.
Beng TS, Chin LE, Guan NC, Yee A, Wu C, Jane LE, et al. Mindfulness-based supportive therapy (MBST): proposing a palliative psychotherapy from a conceptual perspective to address suffering in palliative care. Am J Hosp Palliat Care. 2015;32(2):144–60. https://doi.org/10.1177/1049909113508640.
Feldman DB, Sorocco KH, Bratkovich KL. Treatment of posttraumatic stress disorder at the end-of-life: application of the Stepwise Psychosocial Palliative Care model. Palliat Support Care. 2014;12(3):233–43. https://doi.org/10.1017/S1478951513000370.
Strieder M, Pecherstorfer M, Kreye G. Symptomatic treatment of dyspnea in advanced cancer patients: a narrative review of the current literature. Wien Med Wochenschr. 2018;168(13-14):333–43. https://doi.org/10.1007/s10354-017-0600-4.
Weixler D, Roider-Schur S, Likar R, Bozzaro C, Daniczek T, Feichtner A, Gabl C, Hammerl-Ferrari B, Kletecka-Pulker M, Körtner UH, Kössler H, Meran JG, Miksovsky A, Pusswald B, Wienerroither T, Watzke H. Austrian guideline for palliative sedation therapy (long version): Results of a Delphi process of the Austrian Palliative Society (OPG). Wien Med Wochenschr. 2017;167(1–2):31–48. https://doi.org/10.1007/s10354-016-0533-3. Epub 2016 Dec 6. PMID: 27924420 German.
Beller EM, van Driel ML, McGregor L, Truong S, Mitchell G. Palliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev. 2015;1:CD10206. https://doi.org/10.1002/14651858.CD010206.pub2.PMID:.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
T. Riss declares that she has no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Riss, T. A case report of posttraumatic stress disorder at the end of life. Wien Med Wochenschr 172, 184–188 (2022). https://doi.org/10.1007/s10354-021-00892-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-021-00892-0